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compressor. A smaller proportion specified the use 
of an exhaust device. Ribavirin and colistin were 
used most frequently without an exhaust device. Only 
one of seven consultants used pentamidine without 
an exhaust device. All these drugs were given on 
occasions without any exhaust device being used. 
Thus, nebulized antimicrobial agents had been 
prescribed by a significant proportion of consultant 
physicians and paediatricians, but by fewer geriatri- 
cians. This use potentially exposes hospital staff, 
patients, visitors, and home carers to health risks 
caused by waste aerosol, and possibly an increased 
risk of infection (3-6). Dosages prescribed for 
colistin, the drug most commonly used in this way, 
varied eight-fold, but the doses of other agents used 
seem to be more standardized. 
Unnecessary exposure of health care staff to waste 
aerosol could be reduced by the wider use of exhaust 
devices, but simple measures such as regular checks 
of equipment connections and seals, and use of 
separate treatment rooms should not be overlooked. 
In addition it would seem sensible that manufac- 
turers and clinicians should recognize that these 
agents are sometimes used in unlicensed ways, 
collaborate to produce formulations for use in 
nebulizers, and specify appropriate treatment regimes 
and safety precautions. 
J. R. BEACH, M. CAMPBELL, 
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Dear Editor 
Cattle TB: ‘VL, open’ cases . . . or ‘NVL, 
non-infectious’ cases? 
There seem to be two schools of thought on the 
issue of cattle TB, and yet it is one of critical 
importance in tackling the final stages of tuberculosis 
eradication schemes. On the one hand it is claimed 
that only cattle with gross ‘visible lesions’ (VL) at 
abattoir inspection are capable of passing TB on to 
other cattle (14). 
This view is not substantiated by other studies 
of cattle aetiology and pathogenesis. Most TB in 
adult cattle starts as a lung infection of respiratory 
aerogenous derivation via aerosolized ‘sputum’ or 
dust. Primary lesions may heal, but more usually 
they remain ‘open’, and may remain subclinically 
latent, or progress to chronic, or fatal and acute 
bronchopneumonia. Even where an apparent 
‘sealed tubercle’ develops, it would seem that intra- 
canalicular bronchiolar spread continues, such that 
intermittent or continuous bacterial shedding occurs 
in the ‘sputum’. Even cattle with micro-lesions that 
would be missed at gross abattoir inspection are 
infectious to other cattle despite being ‘non-visibly- 
lesioned’ (NVL) in the lungs, or VL only in 
broncho-mediastinal lymph nodes. Such cattle 
will be producing infectious faeces via swallowed 
‘sputum’ (559). Surely it is the case that the 
number of cattle with TB in a herd merely 
reflects the period elapsed since the last ‘clear’ test, 
NVL or otherwise, there is spread to contiguous 
herds, and slurry is infectious? Pigs, other stock 
and badgers might catch TB from even NVL 
herds? 
M. HANCOX 
I7 Nouncells Cross 
Stroud 
Gloucester, U.K. 
2 May 1995 
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